Intercellular Communication Reveals Therapeutic Potential of Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer

被引:6
|
作者
Liu, Yang [1 ]
Fang, Yu [2 ]
Bao, Lili [1 ]
Wu, Feng [3 ]
Wang, Shilong [1 ]
Hao, Siyu [4 ]
机构
[1] Harbin Med Univ, Pharm Intravenous Admixture Serv, Affiliated Hosp 2, Harbin 150081, Peoples R China
[2] Harbin Med Univ, Dept Phase I Clin Trial Ward, Canc Hosp, Harbin 150081, Peoples R China
[3] Harbin Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Harbin 150001, Peoples R China
[4] Harbin Med Univ, Dept Dermatol, Affiliated Hosp 2, Harbin 150081, Peoples R China
关键词
single-cell transcriptomics; triple-negative breast cancer; epithelial-mesenchymal transition; cell communication; anti-cancer strategy; CELLS; BEVACIZUMAB; DATABASE; ALPHA; EMT;
D O I
10.3390/biom12101478
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
(1) Background: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with high intra-tumoral heterogeneity. The epithelial-mesenchymal transition (EMT) is one of the inducers of cancer metastasis and migration. However, the description of the EMT process in TNBC using single-cell RNA sequencing (scRNA-seq) remains unclear. (2) Methods: In this study, we analyzed 8938 cellular gene expression profiles from five TNBC patients. We first scored each malignant cell based on functional pathways to determine its EMT characteristics. Then, a pseudo-time trajectory analysis was employed to characterize the cell trajectories. Furthermore, CellChat was used to identify the cellular communications. (3) Results: We identified 888 epithelium-like and 846 mesenchyme-like malignant cells, respectively. A further pseudo-time trajectory analysis indicated the transition trends from epithelium-like to mesenchyme-like in malignant cells. To characterize the potential regulators of the EMT process, we identified 10 dysregulated transcription factors (TFs) between epithelium-like and mesenchyme-like malignant cells, in which overexpressed forkhead box protein A1 (FOXA1) was recognized as a poor prognosis marker of TNBC. Furthermore, we dissected the cell-cell communications via ligand-receptor (L-R) interactions. We observed that tumor-associated macrophages (TAMs) may support the invasion of malignant epithelial cells, based on CXCL-CXCR2 signaling. The tumor necrosis factor (TNF) signaling pathway secreted by TAMs was identified as an outgoing communication pattern, mediating the communications between monocytes/TAMs and malignant epithelial cells. Alternatively, the TNF-related ligand-receptor (L-R) pairs showed promising clinical implications. Some immunotherapy and anti-neoplastic drugs could interact with the L-R pairs as a potential strategy for the treatment of TNBC. In summary, this study enhances the understanding of the EMT process in the TNBC microenvironment, and dissections of EMT-related cell communications also provided us with potential treatment targets.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Role of epithelial-mesenchymal transition markers in triple-negative breast cancer
    Cheung, Sai Yin
    Boey, Yvonne Jia Yu
    Koh, Valerie Cui Yun
    Thike, Aye Aye
    Lim, Jeffrey Chun Tatt
    Iqbal, Jabed
    Tan, Puay Hoon
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (03) : 489 - 498
  • [2] Epithelial-Mesenchymal Transition Indexes in Triple-Negative Breast Cancer Progression and Metastases
    Kepuladze, Shota
    Burkadze, George
    Kokhreidze, Irakli
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (09)
  • [3] The Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy and the Epithelial-Mesenchymal Transition
    Zapperi, Stefano
    La Porta, Caterina A. M.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [4] Epithelial-mesenchymal transition and its regulators are major targets of triple-negative breast cancer
    Al Moustafa, Ala-Eddin
    [J]. CELL ADHESION & MIGRATION, 2013, 7 (05) : 424 - 425
  • [5] CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer
    Zeng, Qiqun
    Li, Weidong
    Lu, Di
    Wu, Zhenzhen
    Duan, Hongxia
    Luo, Yongting
    Feng, Jing
    Yang, Dongling
    Fu, Li
    Yan, Xiyun
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (04) : 1127 - 1132
  • [6] Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype
    Jeong, Hoiseon
    Ryu, Young-joon
    An, Jungsuk
    Lee, Youngseok
    Kim, Aeree
    [J]. HISTOPATHOLOGY, 2012, 60 (6B) : E87 - E95
  • [7] Role of epithelial–mesenchymal transition markers in triple-negative breast cancer
    Sai Yin Cheung
    Yvonne Jia Yu Boey
    Valerie Cui Yun Koh
    Aye Aye Thike
    Jeffrey Chun Tatt Lim
    Jabed Iqbal
    Puay Hoon Tan
    [J]. Breast Cancer Research and Treatment, 2015, 152 : 489 - 498
  • [8] Phenotypic Heterogeneity of Triple-Negative Breast Cancer Mediated by Epithelial-Mesenchymal Plasticity
    Kvokackova, Barbora
    Remsik, Jan
    Jolly, Mohit Kumar
    Soucek, Karel
    [J]. CANCERS, 2021, 13 (09)
  • [9] Chemotherapeutic stress influences epithelial-mesenchymal transition and stemness in cancer stem cells of triple-negative breast cancer
    Li, X.
    Strietz, J.
    Bleilevens, A.
    Stickeler, E.
    Maurer, J.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E101 - E101
  • [10] Reprogramming epithelial-mesenchymal transition and the immune microenvironment in triple-negative breast cancer with epigenetic drugs.
    Yuan, Xueying
    Soth, Michael
    Jones, Philip
    Rosen, Jeffrey
    [J]. CANCER RESEARCH, 2022, 82 (23)